Focusing on emerging technologies, products and services improving women’s health and wellness throughout their lives.
Ready for Some Great Pitches?
Companies to be Announced May 1, 2019
Upcoming Pitch Call: May 10, 2019
Missed the last pitch session? Check out the videos here.
March 13, 2019
Fe3 Medical is addressing Iron deficiency anemia in women using a novel delivery modality.
NX Prenatal is the only firm utilizing proprietary exosome-based liquid biopsy techniques to create breakthroughs in maternal-fetal diagnostics.
Pitch evaluation and discussion of Fe3 Medical and NX Prenatal by fund leadership and Portfolia FemTech fund members.
Interested in joining a diligence team? Email us and let us know.
MitraGen is a cardiovascular device company developing a unique and compelling approach to Transcatheter Mitral Valve Repair (TMVR).
UDoTest is a software delivery platform designed to simplify and personalize consumer at-home testing for enterprises.
Sana Health is redefining the way pain is being treated with a non-invasive device helping patients manage chronic pain.
Select a portfolio company below for company updates, open positions, and executive bios so.
Madorra has developed the first effective, non- hormonal treatment and new treatment paradigm for vaginal dryness.
Future Family helps families more easily afford fertility services like IVF and egg freezing.
Prime Genomics is creating innovative new ways to transform the cancer screening market by using saliva testing.